*******WATCHMEN*******

[Mean Weimaraner]

$OBMP news out; "Norepinefrine is approved in Mexico as indicated for the treatment of low blood pressure and heart failure. OncBioMune intends to immediately initiate distribution of Norepinefrine throughout its sales channels across Mexico.

The Norepinefrine registration can also be used in other Central and Latin American countries. OncBioMune is conducting its due diligence with plans to selectively launch the drug in other markets in the future.

"The acquisition of Norepinefrine adds the first big generic medicine to our Mexican product bag and we anticipate it will immediately gain traction with physicians," commented Andrew Kucharchuk, President and Chief Financial Officer at OncBioMune. "We are feeling very confident in our future, given Bekunis(R) had a record sales month in May, the approval of our male fertility product Andfrt(R) two weeks ago and now closing the acquisition of Norepinefrine. Our team is already mobilizing to bring Andfrt(R) and Norepinefrine to market and making sure the supply chain can meet expected demand."